UA82254C2 - Склад та спосіб одержання композиції, фармацевтична композиція та її застосування - Google Patents
Склад та спосіб одержання композиції, фармацевтична композиція та її застосування Download PDFInfo
- Publication number
- UA82254C2 UA82254C2 UAA200603104A UAA200603104A UA82254C2 UA 82254 C2 UA82254 C2 UA 82254C2 UA A200603104 A UAA200603104 A UA A200603104A UA A200603104 A UAA200603104 A UA A200603104A UA 82254 C2 UA82254 C2 UA 82254C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- water
- composition
- solution
- ammonia synthesis
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 77
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 31
- 230000008569 process Effects 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 7
- 238000009472 formulation Methods 0.000 title 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 53
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- 235000019441 ethanol Nutrition 0.000 claims abstract description 28
- 239000002699 waste material Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 26
- 239000003054 catalyst Substances 0.000 claims abstract description 26
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 25
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 25
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910017604 nitric acid Inorganic materials 0.000 claims abstract description 18
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 17
- 239000004599 antimicrobial Substances 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 35
- 239000000645 desinfectant Substances 0.000 claims description 25
- 238000004659 sterilization and disinfection Methods 0.000 claims description 23
- 230000001954 sterilising effect Effects 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 230000000845 anti-microbial effect Effects 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 8
- 230000003993 interaction Effects 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 230000000840 anti-viral effect Effects 0.000 claims description 6
- 229910002804 graphite Inorganic materials 0.000 claims description 6
- 239000010439 graphite Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 230000000855 fungicidal effect Effects 0.000 claims description 5
- 239000003206 sterilizing agent Substances 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 238000009434 installation Methods 0.000 claims description 4
- 238000004381 surface treatment Methods 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 230000002262 irrigation Effects 0.000 claims description 3
- 238000003973 irrigation Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000013980 iron oxide Nutrition 0.000 claims description 2
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000013355 food flavoring agent Nutrition 0.000 claims 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 239000011651 chromium Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 18
- 230000000249 desinfective effect Effects 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000000376 reactant Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 23
- 241000894006 Bacteria Species 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 241000700605 Viruses Species 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 230000003253 viricidal effect Effects 0.000 description 7
- 235000005979 Citrus limon Nutrition 0.000 description 6
- 244000131522 Citrus pyriformis Species 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 229940064004 antiseptic throat preparations Drugs 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 206010011409 Cross infection Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 239000002360 explosive Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000003330 sporicidal effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- GEXJFIOPGAASTP-UHFFFAOYSA-N $l^{1}-azanylethane Chemical compound CC[N] GEXJFIOPGAASTP-UHFFFAOYSA-N 0.000 description 1
- PQMFVUNERGGBPG-UHFFFAOYSA-N (6-bromopyridin-2-yl)hydrazine Chemical compound NNC1=CC=CC(Br)=N1 PQMFVUNERGGBPG-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000005546 Piper methysticum Species 0.000 description 1
- 235000016787 Piper methysticum Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960000587 glutaral Drugs 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003779 heat-resistant material Substances 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N hydrofluoric acid Substances F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- JVJUWCMBRUMDDQ-UHFFFAOYSA-N methylmercuric dicyanamide Chemical compound C[Hg]N=C(N)NC#N JVJUWCMBRUMDDQ-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000002956 necrotizing effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000009428 plumbing Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910001404 rare earth metal oxide Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000000766 tuberculocidal effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GEAP2003005325 | 2003-12-03 | ||
| GEAP2004008516 | 2004-11-26 | ||
| PCT/GE2004/000006 WO2005053714A2 (en) | 2003-12-03 | 2004-12-02 | Disinfecting composition, preparation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA82254C2 true UA82254C2 (uk) | 2008-03-25 |
Family
ID=34655255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200603104A UA82254C2 (uk) | 2003-12-03 | 2004-02-12 | Склад та спосіб одержання композиції, фармацевтична композиція та її застосування |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060292196A1 (enExample) |
| EP (1) | EP1691613A2 (enExample) |
| JP (1) | JP2007513137A (enExample) |
| CN (1) | CN1889843A (enExample) |
| EA (1) | EA010164B1 (enExample) |
| IL (1) | IL174081A0 (enExample) |
| UA (1) | UA82254C2 (enExample) |
| WO (1) | WO2005053714A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9578879B1 (en) | 2014-02-07 | 2017-02-28 | Gojo Industries, Inc. | Compositions and methods having improved efficacy against spores and other organisms |
| JP2017505324A (ja) | 2014-02-07 | 2017-02-16 | ゴジョ・インダストリーズ・インコーポレイテッド | 胞子及び他の生物に対する効力を有する組成物及び方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH629100A5 (de) * | 1979-09-27 | 1982-04-15 | Solco Basel Ag | Hautpraeparat. |
| EP1041879B2 (en) * | 1997-10-10 | 2012-03-21 | Pure Bioscience | Disinfectant and method of making |
| DE10036607A1 (de) * | 2000-07-27 | 2002-02-14 | Henkel Ecolab Gmbh & Co Ohg | Saure Zubereitungen zur Reinigung und Desinfektion von Oberflächen |
| JP2002068914A (ja) * | 2000-08-28 | 2002-03-08 | Nippon Chem Ind Co Ltd | 銀成分を担持した無機系抗菌剤の抗菌活性の増強方法 |
-
2004
- 2004-02-12 UA UAA200603104A patent/UA82254C2/uk unknown
- 2004-12-02 EP EP04801271A patent/EP1691613A2/en not_active Withdrawn
- 2004-12-02 EA EA200600385A patent/EA010164B1/ru not_active IP Right Cessation
- 2004-12-02 JP JP2006542028A patent/JP2007513137A/ja active Pending
- 2004-12-02 WO PCT/GE2004/000006 patent/WO2005053714A2/en not_active Ceased
- 2004-12-02 CN CNA2004800356307A patent/CN1889843A/zh active Pending
-
2006
- 2006-03-02 IL IL174081A patent/IL174081A0/en unknown
- 2006-06-02 US US11/445,918 patent/US20060292196A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA010164B1 (ru) | 2008-06-30 |
| IL174081A0 (en) | 2006-08-01 |
| WO2005053714A2 (en) | 2005-06-16 |
| WO2005053714A3 (en) | 2005-08-18 |
| EP1691613A2 (en) | 2006-08-23 |
| US20060292196A1 (en) | 2006-12-28 |
| CN1889843A (zh) | 2007-01-03 |
| EA200600385A1 (ru) | 2006-08-25 |
| JP2007513137A (ja) | 2007-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20150141938A (ko) | 은이온 항균액의 생성방법, 그 방법으로 생성되는 은이온 항균액 및 그 항균액을 함유한 은이온 함유 제품 | |
| EP3737425A1 (en) | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating | |
| Knapp et al. | Chlorine dioxide | |
| Reddy et al. | Chlorine and the Chemistry of Disinfectants: A Fascinating Journey—18th Century to the COVID Times | |
| Cimolai | Disinfection and decontamination in the context of SARS‐CoV‐2‐specific data | |
| WO2022046955A1 (en) | Methods and uses of producing compositions stably comprising free available chlorine species and peroxides | |
| WO2023019029A1 (en) | Powder disinfectant compositions | |
| US6331514B1 (en) | Sterilizing and disinfecting compound | |
| US20060075922A1 (en) | Controlled-acidity composition | |
| UA82254C2 (uk) | Склад та спосіб одержання композиції, фармацевтична композиція та її застосування | |
| US4654374A (en) | Chemical disinfectant and sterilant | |
| RU2125467C1 (ru) | Дезинфицирующее средство "велтосепт" | |
| RU2796846C1 (ru) | Антисептическое и дезинфицирующее средство | |
| RU2524621C1 (ru) | Стабилизированный противомикробный гелевый состав на основе пероксида водорода | |
| AU2017269086B2 (en) | System and method of cleaning an environment | |
| US20230255211A1 (en) | Powder disinfectant compositions | |
| UA145445U (uk) | Засіб для дезінфекції | |
| Tanwir | Unlocking the Power of Effective Disinfection: Key Factors Revealed | |
| Harrington | Some studies in asepsis | |
| AU2023375559A1 (en) | Compositions comprising stable free available chlorine species and peroxides, methods of making and uses thereof | |
| Manohari et al. | International Journal of Pharmacy and Industrial Research (IJPIR) | |
| BR102021018675B1 (pt) | Sistema para ozonização de líquidos e usos do mesmo | |
| EA013233B1 (ru) | Антисептическая композиция для дезинфекции кожных покровов, способ ее приготовления и полупродукт для ее приготовления | |
| Kelkar | Disinfection and Sterilization | |
| EVANS | Some Contributions to Prevention of Infections |